A. Vijayakumar

发表

METHANOLIC EXTRACT OF BACOPA MONNIERA REDUCE DEVELOPMENT OF TOLERANCE TO ANTIEPILEPTIC EFFECT OF PHENOBARBITONE IN MICE

Seethalakshmi, A. Vijayakumar, M. Vinay, 2015 .

Inhibiting PI3K reduces mammary tumor growth and induces hyperglycemia in a mouse model of insulin resistance and hyperinsulinemia

D. Leroith, S. Yakar, E. Gallagher, 2011, Oncogene.

The GH/IGF-1 axis in growth and development: new insights derived from animal models.

D. Leroith, Dara Cannata, A. Vijayakumar, 2010, Advances in pediatrics.

Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes.

D. Leroith, A. Rowzee, T. Wood, 2010, Cancer research.

Deletion of growth hormone receptors in postnatal skeletal muscle of male mice does not alter muscle mass and response to pathological injury.

D. Leroith, S. Yakar, E. Gallagher, 2013, Endocrinology.

Animal Models of Hyperinsulinemia, Insulin Resistance, and Cancer

D. Leroith, R. Novosyadlyy, A. Vijayakumar, 2011 .

Physical and functional interaction between polyoma virus middle T antigen and insulin and IGF-I receptors is required for oncogene activation and tumour initiation

D. Leroith, R. Novosyadlyy, D. Lann, 2009, Oncogene.

Combinations of an acetyl CoA carboxylase inhibitor with hepatic lipid modulating agents do not augment antifibrotic efficacy in preclinical models of NASH and fibrosis

Saritha Kusam, J. Trevaskis, M. Toteva, 2022, Hepatology communications.

Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.

I. Mikaelian, B. Marchand, Saili Yi, 2020, Journal of hepatology.

Skeletal Muscle Growth Hormone Receptor Signaling Regulates Basal, but Not Fasting-Induced, Lipid Oxidation

D. Leroith, S. Yakar, Xiaosong Li, 2012, PloS one.

The Intricate Role of Growth Hormone in Metabolism

D. Leroith, S. Yakar, A. Vijayakumar, 2011, Front. Endocrin..

Absence of Carbohydrate Response Element Binding Protein in Adipocytes Causes Systemic Insulin Resistance and Impairs Glucose Transport.

A. Saghatelian, G. Shulman, B. Kahn, 2017, Cell reports.

Adipose tissue dysfunction is associated with low levels of the novel Palmitic Acid Hydroxystearic Acids

S. Gogg, U. Smith, B. Kahn, 2018, Scientific Reports.

Growth hormone receptor regulates β cell hyperplasia and glucose-stimulated insulin secretion in obese mice.

Chengyu Liu, D. Leroith, Chengyu Liu, 2011, The Journal of clinical investigation.

PAHSAs attenuate immune responses and promote β cell survival in autoimmune diabetic mice.

A. Saghatelian, D. Mathis, D. Siegel, 2019, The Journal of clinical investigation.

Targeted Loss of GHR Signaling in Mouse Skeletal Muscle Protects Against High-Fat Diet–Induced Metabolic Deterioration

D. Leroith, Chengyu Liu, S. Yakar, 2011, Diabetes.

Targeting lipid biosynthesis pathways for hepatitis B virus cure

William A. Lee, Meghan M. Holdorf, S. Fletcher, 2022, PloS one.

Anti-diabetic therapy inhibits mammary tumor progression Insulin sensitizing therapy attenuates type 2 diabetes-mediated mammary tumor progression Running Title: Anti-diabetic therapy inhibits mammary tumor progression

D. Leroith, S. Yakar, R. Novosyadlyy, 2009 .

Metabolites as regulators of insulin sensitivity and metabolism

B. Kahn, Qin Yang, A. Vijayakumar, 2018, Nature Reviews Molecular Cell Biology.

IGF-1 Cellular Action and its Relationship to Cancer: Evidence from in Vitro and in Vivo Studies

S. Yakar, N. Alikhani, R. D. Ferguson, 2012 .

Type 2 diabetes and cancer: what is the connection?

D. Leroith, Dara Cannata, A. Vijayakumar, 2010, The Mount Sinai journal of medicine, New York.

BCAA Supplementation in Mice with Diet-Induced Obesity Alters the Metabolome Without Impairing Glucose Homeostasis.

O. Ilkayeva, C. Newgard, B. Kahn, 2021, Endocrinology.

Obesity and type 2 diabetes are associated with an increased risk of developing cancer and a worse prognosis; epidemiological and mechanistic evidence.

D. Leroith, S. Yakar, E. Gallagher, 2008, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Insulin-Sensitizing Therapy Attenuates Type 2 Diabetes–Mediated Mammary Tumor Progression

D. Leroith, S. Yakar, R. Novosyadlyy, 2009, Diabetes.

Biological effects of growth hormone on carbohydrate and lipid metabolism.

D. Leroith, S. Yakar, R. Novosyadlyy, 2010, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Insulin-like growth factor-I protects cells from ER stress-induced apoptosis via enhancement of the adaptive capacity of endoplasmic reticulum

D. Leroith, S. Yakar, R. Novosyadlyy, 2008, Cell Death and Differentiation.

Acute Nitrobenzene Poisoning with Severe Methemoglobinemia: A Case Report

Hisham, A. Vijayakumar, N. Rajesh, 2012 .

Mammalian target of rapamycin inhibition abrogates insulin-mediated mammary tumor progression in type 2 diabetes.

D. Leroith, S. Yakar, R. Novosyadlyy, 2010, Endocrine-related cancer.

OR12,3 Insulin-like growth factor I protects cells from ER stress-induced apoptosis via enhancement of the adaptive capacity of endoplasmic reticulum

D. Leroith, S. Yakar, R. Novosyadlyy, 2008 .

Metabolites as regulators of insulin sensitivity and metabolism

B. Kahn, Qin Yang, A. Vijayakumar, 2018, Nature Reviews Molecular Cell Biology.

Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes.

D. Leroith, A. Rowzee, T. Wood, 2010, Cancer research.

The GH/IGF-1 axis in growth and development: new insights derived from animal models.

D. Leroith, Dara Cannata, A. Vijayakumar, 2010, Advances in pediatrics.

Absence of Carbohydrate Response Element Binding Protein in Adipocytes Causes Systemic Insulin Resistance and Impairs Glucose Transport.

A. Saghatelian, G. Shulman, B. Kahn, 2017, Cell reports.